Biobanking Market Predicted to Witness Highest Revenues 2027

 Growing trend of personalised medicines to reduce mortality rates caused by chronic diseases is fuelling demand for biobanks for the effective storage of numerous biospecimen, ranging from blood to tissues, cells, and nucleic acids. Sales of equipment for storing biospecimen would surge, and temperature control systems are projected to cross the US$ 1 Bn mark by 2027. A notable spurt in adoption of freezers for the preservation of biospecimen for their future use is likely to underpin growth of temperature control systems. However, a shift from manual to automated systems would boost opportunities for software and services during the forecast period (2020-2027).

Request Free Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4438

In the making of the biobanking market study, the following are taken into:

  • History Period: 2014 – 2018
  • Base Period: 2018
  • Estimated Year: 2019
  • Forecast Period: 2019 – 2029

Interested market participants and readers can peruse the global market biobanking report to get insights into and evaluation of:

  • Key growth drivers and restraints, trends and opportunities, and major challenges influencing the adoption rate of offerings by various players in the biobanking market
  • Major research and product development projects
  • Promising technologies and favorable regulations in key regions
  • Segments that will lose or gain shares in the next few years
  • Value chain of key vendors and manufacturers

The biobanking market report provides estimations and the market sizing and prospects of various regions. To this end, the study makes in-depth segmentation of the following key regions:

  • North America
  • Latin America
  • Europe
  • Japan
  • APEJ
  • MEA

The study also takes a closer look at the prevailing regulatory and macroeconomic frameworks and in the key country markets.

Fact.MR has been closely tracking shares and size, and factors shaping the demand and consumption dynamics of various offering by key players in the biobanking market over the past several years. To this end, the study segments the biobanking market on the following product types:

  • Equipment
  • Consumables
  • Software & Services

Detailed profiling of the competitive landscape include following players:

  • PHC Holdings Corporation (Panasonic Healthcare),
  • Merck KGaA,
  • Hamilton Company,
  • Brooks Automation, Inc.,
  • Chart Industries, Inc.,
  • Greiner AG,
  • VWR International, LLC,
  • QIAGEN N.V.

Fact.MR strives to offer market analytics and business intelligence solutions to guide businesses in better strategy formulations in the biobanking market.

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4438

 The biobanking market report will improve the revenue impact of businesses in various industries by:

  • Providing a framework tailored toward understanding the attractiveness quotient of various products/solutions/technologies in the biobanking market
  • Guiding stakeholders to identify key problem areas pertaining to their consolidation strategies in the global biobanking market and offers solutions
  • Assessing the impact of changing regulatory dynamics in the regions in which companies are keen on expanding their footprints
  • Provides understanding of disruptive technology trends to help businesses make their transitions smoothly
  • Helping leading companies make strategy recalibrations ahead of their competitors and peers
  • Offers insights into promising synergies for top players aiming to retain their leadership position in the biobanking market.

Matched content

Editor’s pick

Do NOT follow this link or you will be banned from the site!